You have 9 free searches left this month | for more free features.

Multiple Sclerosis

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsing Remitting Multiple Sclerosis Trial in Glasgow (Clinical assessment)

Enrolling by invitation
  • Relapsing Remitting Multiple Sclerosis
  • Clinical assessment
  • Glasgow, United Kingdom
    Clinical Research Facility
Jul 20, 2022

Inflammatory Disease in Multiple Sclerosis

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Multiple Sclerosis
  • Cerebrospinal and Blood Serum Semaphorin 4A Levels
  • Portland, Oregon
    Providence St. Vincent Medical Center
May 19, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Paris (50 ml blodd sampling)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • 50 ml blodd sampling
  • Paris, France
    Hôpital La Pitié - Salpêtrière
Aug 16, 2022

Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

Not yet recruiting
  • Multiple Sclerosis (MS)
  • +6 more
  • Clemastine Fumarate
  • Placebo
  • San Francisco, California
    Sandler Neurosciences Building, Neurological Clinical Research U
Jul 27, 2022

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco

Recruiting
  • Multiple Sclerosis
  • +2 more
  • N-acetyl cysteine
  • Placebo
  • San Francisco, California
    University of California, San Francisco
Mar 22, 2022

Multiple Sclerosis Trial in Izmir (Exergaming)

Recruiting
  • Multiple Sclerosis
  • Exergaming
  • İzmir, Turkey
    Dokuz Eylul University
Jun 10, 2022

Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • 3 mg Melatonin
  • 5 mg Melatonin
  • Portland, Oregon
    Providence MS Center
May 5, 2022

Experiences of Multiple Sclerosis Patients

Not yet recruiting
  • Multiple Sclerosis
    • (no location specified)
    Aug 12, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

    Recruiting
    • Secondary Progressive Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
    • Placebo oral tablet identical to metformin, up to 4 tablets a day
    • Los Angeles, California
      University of California, Los Angeles
    May 2, 2022

    Telerehabilitation Interventions in Multiple Sclerosis

    Recruiting
    • Multiple Sclerosis
    • telerehabilitation
    • İzmir, Turkey
      Dokuz Eylul University
    Oct 6, 2022

    Multiple Sclerosis Intimacy and Sexuality Questionnaire

    Completed
    • Multiple Sclerosis
    • +2 more
    • descriptive study
    • Yozgat, Turkey
      Yozgat Bozok University
    May 11, 2022

    Multiple Sclerosis Trial in New York (Vancomycin, Placebo)

    Not yet recruiting
    • Multiple Sclerosis
    • New York, New York
      Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mou
    Sep 12, 2022

    Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Ixazomib (NINLARO®) capsules / Matching placebo capsules
    • London, Greater London, United Kingdom
      Royal London Hospital, Barts Health NHS Foundation Trust
    Feb 17, 2022

    Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic

    Recruiting
    • Multiple Sclerosis, Primary Progressive
    • Multiple Sclerosis, Secondary Progressive
    • Magnetic Resonance Imaging
    • +3 more
    • Marseille, France
    • +1 more
    Jan 14, 2022

    Multiple Sclerosis Trial in Selçuklu (Yönetebilirim)

    Recruiting
    • Multiple Sclerosis
    • Yönetebilirim
    • Selçuklu, Konya, Turkey
      Selcuk University
    Jul 4, 2022

    Multiple Sclerosis Fatigue Trial (Ketamine, Midazolam)

    Not yet recruiting
    • Multiple Sclerosis Fatigue
    • (no location specified)
    May 17, 2022

    Pharmacogenetics of Liver Toxicity in Multiple Sclerosis Treated

    Recruiting
    • Multiple Sclerosis
    • Genetic polymorphism
    • Measurement of fingolimod and fingolimod-phosphate concentrations
    • Caen, France
      Caen University Hospital
    Aug 23, 2022

    5-HT7 Receptor Implication in Inflammatory Mechanisms in

    Completed
    • Multiple Sclerosis, Acute Relapsing
    • Multiple Sclerosis
    • blood sampling
    • Orléans, France
      CHR Orléans
    Feb 16, 2022

    Multiple Sclerosis Trial in Istanbul (Reiki)

    Recruiting
    • Multiple Sclerosis
    • Reiki
    • Istanbul, Güneydoğu Anadolu Bölgesi, Turkey
      Istanbul Sabahattin Zaim University, Faculty of Health Sciences
    Jul 12, 2022

    Multiple Sclerosis, Relapsing-Remitting, Sexual Dysfunction Trial in Birmingham (Behavioural intervention for physical activity

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Sexual Dysfunction
    • Behavioural intervention for physical activity for multiple sclerosis (BIPAMS)
    • Birmingham, Alabama
      University of Alabama at Birmingham
    May 7, 2022

    T Cell Profiling in Patients With Multiple Sclerosis

    Not yet recruiting
    • Multiple Sclerosis
    • Blood Sample
    • Boston, Massachusetts
      Boston Children's Hopsital
    Aug 6, 2022

    Multiple Sclerosis Trial (exercise)

    Not yet recruiting
    • Multiple Sclerosis
    • exercise
    • (no location specified)
    Oct 5, 2022

    Multiple Sclerosis Trial (Cannabis oil vs )

    Not yet recruiting
    • Multiple Sclerosis
    • Cannabis oil vs placebo
    • (no location specified)
    Aug 16, 2022

    Multiple Sclerosis Trial in Ankara (Muscles Fatigue)

    Completed
    • Multiple Sclerosis
    • Muscles Fatigue
    • Ankara, Turkey
      Gazi University
    Aug 4, 2022

    Multiple Sclerosis Trial in Kahramanmaras (Assesment)

    Not yet recruiting
    • Multiple Sclerosis
    • Assesment
    • Kahramanmaraş, Turkey
      Kahramanmaraş Sutcu Imam University
    Jul 7, 2022